Risk factors and drug resistance in early-onset neonatal group B streptococcal disease / 浙江大学学报(英文版)(B辑:生物医学和生物技术)
Journal of Zhejiang University. Science. B
;
(12): 973-978, 2018.
Article
Dans Anglais
| WPRIM
| ID: wpr-1010437
ABSTRACT
In recent years, group B streptococcus (GBS) has become an important pathogen that causes infections in many neonatal organs, including the brain, lung, and eye (Ballard et al., 2016). A series of studies performed on GBS infections in western countries have revealed that GBS is one of the primary pathogens implicated in perinatal infection, and GBS infections are a major cause of neonatal morbidity and mortality in the United States (Decheva et al., 2013). In China, GBS is mainly found by screens for adult urogenital tract and perinatal infections, and neonatal GBS infections have been rarely reported. The incidence rate of early-onset neonatal GBS disease is thought to be lower in China than in western countries; however, this data is controversial since it also reflects the clinical interest in GBS (Dabrowska-Szponar and Galinski, 2001).
Texte intégral:
Disponible
Indice:
WPRIM (Pacifique occidental)
Sujet Principal:
Parité
/
Complications infectieuses de la grossesse
/
Infections à streptocoques
/
Streptococcus agalactiae
/
Résistance aux substances
/
Chine
/
Incidence
/
Facteurs de risque
/
Résistance bactérienne aux médicaments
/
Antibactériens
Limites du sujet:
Adulte
/
Femelle
/
Humains
/
Grossesse
Pays comme sujet:
Asie
langue:
Anglais
Texte intégral:
Journal of Zhejiang University. Science. B
Année:
2018
Type:
Article
Documents relatifs à ce sujet
MEDLINE
...
LILACS
LIS